Presentation TCT 2025

Cost-Effectiveness of CABG vs. PCI for Multivessel Disease: The FAME 3 Trial

Presenter: Mark Andrew Hlatky

October 25, 2025

REGISTER for free or LOG IN to view this content

TCT 2025

Up Next

Presentation TCT 2025

Five-Year Outcomes of Biodegradable-Polymer Versus Durable-Polymer Second-Generation Drug-Eluting Stents: A Collaborative Individual Patient Data Analysis of 40,214 Patients Enrolled in 22 Randomized Trials

Presenter: Daniele Giacoppo

October 25, 2025

More slides +

Presentation TCT 2025

Real-World Registry of Paclitaxel Drug-Coated Balloon for Native Coronary Artery Disease Treatment

Presenter: Masato Nakamura

October 25, 2025

Presentation TCT 2025

Angiographic Performance Following PCI With a Sirolimus-Eluting Balloon in De Novo Coronary Artery Lesions: The GINGER Study

Presenter: Antonio Colombo

October 25, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.